Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
The market for COVID-19 rapid test kits has experienced a notable decline in recent years, reflecting changes in disease spread and healthcare priorities. Despite this downturn, the market is expected to rebound and grow starting in 2025. Understanding the current landscape, key drivers, segmentation, trends, and competitive players provides a clear picture of the future prospects for this important diagnostic sector.
COVID-19 Rapid Test Kits Market Size and Projected Growth
The COVID-19 rapid test kits market has sharply decreased in recent times, largely due to reduced transmission of infectious diseases, limited growth in diagnostic lab infrastructure, fewer public health testing campaigns, and constrained production capacities for rapid tests. However, starting from $67.38 billion in 2025, the market is anticipated to grow, signaling renewed demand and expanded use in coming years.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=4013&type=smp
Healthcare Spending as a Key Growth Catalyst in the COVID-19 Rapid Test Kits Market
One significant factor expected to boost the COVID-19 rapid test kits market is the steady increase in healthcare expenditure. This spending encompasses the total financial resources allocated to healthcare goods and services within economies and is essential for the development and availability of testing kits.
For example, the Centers for Medicare & Medicaid Services (CMS) reported that in 2023, the National Health Expenditure (NHE) in the United States rose by 7.5% to reach $4.9 trillion, amounting to $14,570 per capita and representing 17.6% of GDP. Hospital spending grew even faster at 10.4%, reaching $1.52 trillion. This upward trend in healthcare funding is a major driver for expanding access to and production of COVID-19 rapid test kits.
Detailed Breakdown of the COVID-19 Rapid Test Kits Market
The market is segmented based on several criteria to better understand product types, specimen sources, and end users:
1) Test Type: RT PCR Test, Rapid Antigen Test, Rapid Antibody Test, and Other Test Types
2) Specimen Type: Nasopharyngeal Swab, Oropharyngeal Swab, Nasal Swab, Blood, and Others
3) End-Users: Hospitals and Clinics, Diagnostic Laboratories, Home Care, and Other End-Users
Additional subcategories include:
– RT PCR Tests further divided into Conventional RT PCR, Real-Time RT PCR, and Automated RT PCR Systems
– Rapid Antigen Tests such as Nasal Swab Antigen Tests, Saliva-Based Antigen Tests, and Lateral Flow Assays
– Rapid Antibody Tests including IgM or IgG Rapid Tests, Lateral Flow Serological Tests, and ELISA Kits
– Other Test Types comprising Combination Tests, Molecular Diagnostics, and Home Test Kits
Access The Complete COVID-19 Rapid Test Kits Market Report:
https://www.thebusinessresearchcompany.com/report/covid-19-rapid-test-kits-global-market-report
Innovations and Trends Shaping the COVID-19 Rapid Test Kits Market
Leading companies in the rapid test kits sector are focusing on developing faster and more accurate products to manage viral outbreaks effectively. Antigen Rapid Test Kits, which detect viral proteins related to infections like COVID-19, provide results quickly—typically within 15 to 30 minutes—from nasal or throat swabs. Although these tests are somewhat less sensitive than PCR-based methods, they are highly effective for rapid screening in large groups.
As an example, in June 2023, Japan’s Kaneka Corporation launched the KANEKA Immunochromatography Flu A/B and SARS-CoV-2 Ag test. This kit can detect both influenza and COVID-19 viruses from a single nasal swab sample in about ten minutes. Its easy-to-use design requires no specialized equipment, making it suitable for clinical and at-home testing. Additionally, its ability to identify multiple viruses simultaneously enhances clinical decision-making and treatment.
Competitive Landscape of the COVID-19 Rapid Test Kits Market
The market includes a range of prominent players striving to innovate and capture market share. Some of the key companies are Abbott Laboratories, F. Hoffmann-La Roche AG, Becton Dickinson and Company, Quidel Corporation, DiaSorin S.p.A., Mylab Discovery Solutions, Beijing Jinwofu Bioengineering Technology Company, Zhejiang Orient Gene Biotech Co. Ltd, Transasia Bio Medicals, Vanguard Diagnostics, SD Biosensor, Getein Biotech, Hangzhou Biotest Biotech, Boditech Med Inc, Beijing Tigsun Diagnostics, Hunan Lituo Biotechnology, Vivacheck Lab, Fujirebio, Atomo Diagnostics, Senova, CerTest Biotec, Omega Diagnostics, Abingdon Health, Novacyt Group, BioMaxima S.A, SensDx S.A, OraSure Technologies Inc, Sorrento Therapeutics, Monocent Inc, Aurora Biomed, Hologic, Mesa Biotech, Healgen Scientific Limited Liability Company, NTBIO Diagnostics, Motologic, ACRO Biotech, Cellex Inc, Advagen Biotech Ltd, BioMedomics, and CapeBio.
Regional Overview Highlighting COVID-19 Rapid Test Kits Market Leaders
In 2025, North America emerged as the largest regional market for COVID-19 rapid test kits, holding the highest revenue share. Western Europe ranked second in terms of market size. The analysis also covers key geographic areas including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a global perspective on future market directions.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
